News and Trends 19 Dec 2016
Evotec closes the year partnering with Celgene to treat Alzheimer’s
…into solid tumors, inflammatory diseases, and now neurodegenerative conditions, which will include Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS) among others. With these ambitious targets, both Celgene and Evotec could…